REDONNA is a mixed-methods randomized study testing the effectiveness of individualized prescribing Portraits to reduce inappropriate initiation of
This changed my practice
Can We Identify Patients at Risk for Opioid Use Disorder when Beginning Opioid Analgesics for Pain from New or Ongoing Non-cancer Causes? There is
Expanding opioid agonist therapy while learning from HIV/AIDS
Accessing opioid agonist therapy (OAT) and maintaining good adherence faces many barriers which can be geographical, financial, regulatory,
Irish Canadian project highlights global issue
This toolkit is based on a study that aimed to establish the feasibility and accessibility of training primary care practitioners in addiction
Towards a research agenda for addiction education in Europe, u21 poster
u21 health sciences group 2020 virtual meeting: A collaborative approach to healthcare was hosted by University College Dublin from August 25th -
Can prescribers avoid contributing to opioid use disorder?
A 21 y/o has surgery for a condition expected to improve. He fills a discharge prescription for 5 days of an opioid at a standard dose. At 1-week
Addiction training provision must meet training needs
Closing the gap between training needs and training provision in addiction medicine Substance use disorders pose a significant
Pain Management with Opioids in 2019-2020
This JAMA Insights Clinical Update reviews evidence-based use of opioids to manage noncancer pain, proposing opioid-sparing pain management. Based on
Boost for Oral Opioid Agonist Therapy
Although opioid agonist treatment is effective in treating opioid use disorders, retention in such treatment is suboptimal in part due to quality of